Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.
作者信息
Moran Angelica, Beavis Kathleen G, Matushek Scott M, Ciaglia Carol, Francois Nina, Tesic Vera, Love Nedra
机构信息
Department of Pathology, The University of Chicago, Chicago, Illinois, USA.
Department of Pathology, The University of Chicago, Chicago, Illinois, USA
出版信息
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00772-20.
Abstract
摘要
相似文献
1
Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.使用赛沛Xpert Xpress SARS-CoV-2检测系统和罗氏cobas SARS-CoV-2检测法检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00772-20.
2
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.雅培 ID Now COVID-19 快速核酸扩增检测试剂使用鼻咽拭子和干鼻拭子在纽约市学术机构中运输的病毒运输介质的性能。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01136-20.
3
Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.罗氏Cobas 6800与赛沛GeneXpert Xpress SARS-CoV-2检测在高循环阈值范围内的检测一致性
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01187-20.
4
Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients.雅培ID Now与雅培m2000方法用于检测有症状患者鼻咽拭子和鼻拭子中新型冠状病毒的比较。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00798-20.
5
Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19.雅培ID Now、索林集团Simplexa以及美国疾病控制与预防中心（CDC）和美国食品药品监督管理局（FDA）紧急使用授权方法用于从确诊为COVID-19的个体的鼻咽拭子和鼻拭子中检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的比较
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00760-20.
6
Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.使用赛沛Xpert Xpress SARS-CoV-2检测有症状患者唾液作为检测SARS-CoV-2的替代样本来源
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01109-20.
7
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.赛沛Xpert Xpress SARS-CoV-2检测的多中心评估
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00926-20.
8
Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.SARS-CoV-2 大流行期间赛沛 Xpert® Xpress SARS-CoV-2 即时检测的多中心评估。
J Clin Virol. 2020 Jul;128:104426. doi: 10.1016/j.jcv.2020.104426. Epub 2020 May 11.
9
Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2.BioFire(R) 呼吸道Panel 2.1 临床评估及 SARS-CoV-2 的检测。
J Clin Virol. 2020 Aug;129:104538. doi: 10.1016/j.jcv.2020.104538. Epub 2020 Jul 6.
10
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens.针对口咽拭子样本中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）检测的赛沛Xpert Xpress SARS-CoV-2检测法的多中心评估
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01288-20.
引用本文的文献
1
Comparative evaluation of GeneXpert and reverse transcription polymerase chain reaction for SARS-CoV-2 diagnosis: a retrospective study.新冠病毒（SARS-CoV-2）诊断中GeneXpert与逆转录聚合酶链反应的比较评估：一项回顾性研究
Access Microbiol. 2025 Aug 21;7(8). doi: 10.1099/acmi.0.000643.v5. eCollection 2025.
2
Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 test on nasal and nasopharyngeal swabs.对赛沛Xpert Xpress新型冠状病毒2检测在鼻拭子和鼻咽拭子上的前瞻性多中心评估。
J Clin Microbiol. 2024 Dec 11;62(12):e0121924. doi: 10.1128/jcm.01219-24. Epub 2024 Nov 6.
3
Diagnostic performance of a point-of-care molecular system for the detection of SARS-CoV-2 in Peru.秘鲁即时检测点分子系统对 SARS-CoV-2 的检测性能。
Rev Peru Med Exp Salud Publica. 2024 May 27;41(1):76-82. doi: 10.17843/rpmesp.2024.411.13046.
4
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (December 2023).美国传染病学会关于 COVID-19 的诊断指南：分子诊断检测（2023 年 12 月）。
Clin Infect Dis. 2024 Jun 27;78(7):e385-e415. doi: 10.1093/cid/ciad646.
5
Comparison of cycle-threshold-values between two commercial SARS-CoV-2 PCR assays.两种商用严重急性呼吸综合征冠状病毒2聚合酶链反应检测方法的循环阈值比较。
EXCLI J. 2023 Apr 4;22:397-399. doi: 10.17179/excli2023-5981. eCollection 2023.
6
Clinical Evaluation of BioFire COVID-19 Test, BioFire Respiratory Panel 2.1, and Cepheid Xpert Xpress SARS-CoV-2 Assays for Sample-to-Answer Detection of SARS-CoV-2.BioFire COVID-19 测试、BioFire 呼吸道Panel 2.1 与 Cepheid Xpert Xpress SARS-CoV-2 检测试剂盒对 SARS-CoV-2 样本至报告结果检测的临床评估
Genes (Basel). 2023 Jan 16;14(1):233. doi: 10.3390/genes14010233.
7
Rapid Evaluation of the Xpert Xpress CoV-2 and Xpert Xpress CoV-2/Flu/RSV Tests.Xpert Xpress新型冠状病毒2检测法和Xpert Xpress新型冠状病毒2/流感/呼吸道合胞病毒检测法的快速评估
Diagnostics (Basel). 2022 Dec 22;13(1):34. doi: 10.3390/diagnostics13010034.
8
SARS-CoV-2 Anti-Spike IgG Antibody and ACE2 Receptor Binding Inhibition Levels among Breakthrough Stage Veteran Patients.突破阶段老年患者的 SARS-CoV-2 刺突 IgG 抗体和 ACE2 受体结合抑制水平。
Microbiol Spectr. 2022 Dec 21;10(6):e0274722. doi: 10.1128/spectrum.02747-22. Epub 2022 Nov 21.
9
Laboratory detection of SARS-CoV-2: A review of the current literature and future perspectives.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的实验室检测：当前文献综述与未来展望
Heliyon. 2022 Oct 3;8(10):e10858. doi: 10.1016/j.heliyon.2022.e10858. eCollection 2022 Oct.
10
Agile design and development of a high throughput cobas SARS-CoV-2 RT-PCR diagnostic test.高通量 cobas SARS-CoV-2 RT-PCR 诊断测试的敏捷设计与开发
Heliyon. 2022 Sep 11;8(9):e10591. doi: 10.1016/j.heliyon.2022.e10591. eCollection 2022 Sep.
本文引用的文献
1
Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis.人类新型冠状病毒感染（COVID-19）：一项范围综述与荟萃分析
J Clin Med. 2020 Mar 30;9(4):941. doi: 10.3390/jcm9040941.
2
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020.2020 年 1 月 24 日至 2 月 21 日，世卫组织欧洲区域出现 2019 冠状病毒病（COVID-19）首例病例。
Euro Surveill. 2020 Mar;25(9). doi: 10.2807/1560-7917.ES.2020.25.9.2000178.
3
Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.中国2019年冠状病毒病疫情的特征及公共卫生应对措施
J Clin Med. 2020 Feb 20;9(2):575. doi: 10.3390/jcm9020575.
4
Presumed Asymptomatic Carrier Transmission of COVID-19.新冠病毒无症状感染者的传播。
JAMA. 2020 Apr 14;323(14):1406-1407. doi: 10.1001/jama.2020.2565.
5
Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea.韩国 2019 年新型冠状病毒（2019-nCoV）疾病早期病例的流行病学特征。
Epidemiol Health. 2020;42:e2020007. doi: 10.4178/epih.e2020007. Epub 2020 Feb 9.
6
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
7
First Case of 2019 Novel Coronavirus in the United States.美国首例 2019 新型冠状病毒病例。
N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.
8
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.德国一名无症状接触者传播2019新型冠状病毒感染
N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.
Zotero 插件